Drugs

Computational Toxicology

FDA Center for Drug Evaluation and Research (CDER) records are a unique repository of the results of clinical and non-clinical studies and post-marketing clinical adverse events. With major advances in computers and information technology, this unique scientific and regulatory information resource can now be more effectively used to address pre- and post-marketing issues. These issues include improving the scientific basis of regulatory actions, supporting guidance development, and contributing to the general advancement of science and product development.

Page Last Updated: 05/05/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English